There is a diversity of chemicals to which humans are potentially exposed. Few of these chemicals have linked human biomonitoring data, and most have very limited neurotoxicity testing. Of particular concern are environmental exposures impacting children, who constitute a population of heightened susceptibility due to rapid neural growth and plasticity, yet lack biomonitoring data compared to other age/population subgroups. This study set out to develop a prioritized list of neuroactive substances, titled the E nvironmental N eu R oact I ve CH emicals (ENRICH) list, to be used as a defined screening library in the evaluation of human biological samples, with emphasis on early childhood-relevant environmental exposures. In silico database mining approaches were used to prioritize chemicals based upon likelihood of neuroactivity, human exposure, and feasible detection in biological samples. Evidence of neuroactivity was compiled across in vitro high-throughput screening, animal testing, and/or human epidemiological findings. Chemicals were considered for their likelihood of human exposure and detection presence in biological samples (including metabolites), with additional evidence indicating presence within child-relevant products. The resulting list of 1827 chemicals were ranked using a Chemical Prioritization Index. Manual inclusion/exclusion criteria were employed for the top-ranking chemical candidates to ensure that chemicals were within the study’s scope (i.e., environmentally relevant) and, for the purposes of biomonitoring, had properties amenable to mass spectrometry methods. These elements were combined to produce the ENRICH list of 250 top-ranking chemicals, spanning pesticides and those used in home maintenance, personal care, cleaning products, vehicles, arts and crafts, and consumer electronics, among other sources. Chemicals were additionally evaluated for high-throughput toxicokinetics to predict how much of a chemical and/or its metabolite(s) may reach urine, as an example biological matrix for practical use in biomonitoring efforts. This novel study couples databases and in silico-based predictions to prioritize chemicals in the environment with potential neurological impacts for future study.
Human exposome features a highly expansive chemical space and substantial individual variability. Although screenings of xenobiotic compounds have revealed exposure landscapes of specific compounds, significant bottlenecks remain in profiling their biotransformed products for comprehensive exposome-wide analysis, including limitations to known metabolites, challenges in new metabolite annotation and low throughput. In this study, we develop an untargeted metabolomics-based compound metabolite discovery network (CMDN) to facilitate high-throughput annotation of xenobiotic metabolites. CMDN integrates a triple-layered architecture comprising a differential expression metabolic space, a rule-based pseudo-MS1 candidature space and an MS2 spectrum similarity network. The utilities and advantages are demonstrated using pesticides as a representative example, given their widespread human exposure and well-documented toxicity. Coupled with enzymatic biotransformation assays involving 1,021 pesticides, CMDN non-redundantly annotated 2,886 bio-transformed derivatives. Following multi-channel validation including standard verification, retention time prediction, murine studies, and enzymatic kinetics, identified metabolites were screened in a human cohort, revealing a novel, diverse and extensive exposure spectrum. Collectively, this study establishes, for the first time, a scalable workflow for the annotation and screening of previously undercharacterized xenobiotic metabolites with unprecedented throughput, representing a significant advancement towards the characterization, interpretation, and prioritization of the human exposome.
Background: Environmental chemicals are hypothesized to contribute to the development of neurodevelopmental disorders; however, only a fraction of the thousands of chemicals in common commercial use have validated assays. We recently developed the Environmental NeuRoactIve Chemicals (ENRICH) list of 250 chemicals prioritized for further testing due to their high likelihood of neuroactivity and human exposure, as derived through analysis across eight neuroactivity, exposure, and detection databases. Measuring some of these compounds in human biological media remains challenging due to the lack of information regarding their metabolites and detection frequencies. Methods: We created an LC-MS/MS database based on the targets in the ENRICH list using S9 human liver fractions to metabolize compounds individually and in groups into newly and previously discovered phase I metabolites. Results: The final database consisted of 274 compounds with 94 parent compounds and 182 metabolites being featured. A total of 55 novel metabolites were discovered. The confidence of the compounds, which were annotated correctly within the database, was high, increasing the odds of positive identifications within future exposomic work. The confidence of the annotations fell between the levels 1–3, with levels one and two consisting of 87% of the database. Conclusions: The creation of this database creates the opportunity for future biological studies centered around the impact these compounds and their metabolites have on the brain and for a better understanding of neurodevelopmental disorders and their origins.